LY4086940 - Eli Lilly
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=460 | Not yet recruiting | Sponsor: Eli Lilly and Company 
New P2 trial • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
http://clinicaltrials.gov/ct2/show/NCT07890376
 
Oct 23, 2026
 
Prev Next